Labshake search
Citations for Immune Technology :
1 - 8 of 8 citations for 7 CHLORO 10 11 DIHYDRO 5H DIBENZ B F ACEPIN 2 OL since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... Omicron BA.1 or Omicron BA.2 (Immune Technology) diluted to 5 μg/ml in 1X PBS and incubated overnight at 4 °C ...
-
bioRxiv - Immunology 2023Quote: ... they were stained with 10 μg/ml of recombinant SIVmac239 Env gp140-biotin (Immune Technology) for 30 minutes at 4°C ...
-
bioRxiv - Immunology 2023Quote: ... and next intracellularly stained with 10 μg/ml of recombinant SIVmac239 Env gp140-biotin (Immune Technology) for 30 minutes at 4°C ...
-
bioRxiv - Immunology 2023Quote: ... they were next stained with 10 μg/ml of recombinant SIVmac239 Env gp140-biotin (Immune Technology) for 30 minutes at 4°C ...
-
bioRxiv - Bioengineering 2024Quote: ... were coated with 0.8 µg/mL recombinant HIVJR-CSF gp120 (for detecting 10-1074; Immune Technology, Tarrytown ...
-
bioRxiv - Immunology 2021Quote: The expression of SARS-CoV-2 S protein in eVLP preparations was analyzed by western blotting as described previously [18] using rabbit polyclonal Ab (pAb) anti-spike protein of SARS-CoV-2 (Immune Technology Corp) followed by detection with goat anti-rabbit IgG-Fc horseradish peroxydase-conjugated (Bethyl) ...
-
bioRxiv - Immunology 2023Quote: ... Plates were coated with 2 μg/mL of recombinant HA protein from A/Puerto Rico/8/1934 (H1N1) virus strain (Immune Technology Corp.) overnight at 4°C ...
-
bioRxiv - Bioengineering 2023Quote: The model vaccines included an antigen of either 1.5 μg dose of RBD-NP (University of Washington) or 10 μg dose of gp120 (SIV/mac239, Immune Technology Corporation). Depending on the formulations ...